Article
Stem Cell-Derived Exosomes with High Expression of PD-L1 as Nanotherapeutics in Rheumatoid Arthritis Model Mice
1 Jul 2025
Abstract excerpt
Purpose: Previous studies have identified synovial T cells as key pathogenic drivers of rheumatoid arthritis (RA). To explore a novel therapeutic strategy targeting these cells, we aimed to develop mesenchymal stem cell-derived exosomes with enhanced PD-L1 expression (Exo-PD-L1) and evaluate their therapeutic potential in RA. Methods: Mouse bone marrow mesenchymal stem cells (MSCs) were stimulated with interferon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
